Skip to main content

Peer Review reports

From: Ivermectin compared with placebo in the clinical course in Mexican patients with asymptomatic and mild COVID-19: a randomized clinical trial

Original Submission
13 May 2022 Submitted Original manuscript
12 Aug 2022 Reviewed Reviewer Report
6 Sep 2022 Reviewed Reviewer Report
6 Oct 2022 Author responded Author comments - Carmen de la Rocha
Resubmission - Version 2
6 Oct 2022 Submitted Manuscript version 2
3 Nov 2022 Author responded Author comments - Carmen de la Rocha
Resubmission - Version 3
3 Nov 2022 Submitted Manuscript version 3
8 Nov 2022 Author responded Author comments - Carmen de la Rocha
Resubmission - Version 4
8 Nov 2022 Submitted Manuscript version 4
11 Nov 2022 Author responded Author comments - Carmen de la Rocha
Resubmission - Version 5
11 Nov 2022 Submitted Manuscript version 5
Publishing
21 Nov 2022 Editorially accepted
8 Dec 2022 Article published 10.1186/s12879-022-07890-6

You can find further information about peer review here.

Back to article page